11/19/24 16:15 | 11/15/24 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 8 | 5 | 170 | D | | | | | | | | | | | | | | |
11/19/24 16:15 | 11/18/24 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | DO | CEO,P | S.d | -1 | 0.5409 | 0 | -3 | -1 | 170 | D | | | | | | | | | | | | | | |
10/29/24 18:24 | 10/27/24 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 28 | 20 | 165 | D | | | | | | | | | | | | | | |
10/29/24 18:24 | 10/28/24 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | DO | CEO,P | S.d | -6 | 0.6901 | 0 | -9 | -5 | 165 | D | | | | | | | | | | | | | | |
8/19/24 17:38 | 8/15/24 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 8 | 6 | 146 | D | | | | | | | | | | | | | | |
8/19/24 17:38 | 8/16/24 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | DO | CEO,P | S.d | -2 | 0.8400 | 0 | -3 | -2 | 146 | D | | | | | | | | | | | | | | |
5/17/24 20:18 | 5/15/24 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 8 | 6 | 141 | D | | | | | | | | | | | | | | |
5/17/24 20:18 | 5/15/24 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | DO | CEO,P | S.d | -2 | 0.9400 | 0 | -2 | -2 | 141 | D | | | | | | | | | | | | | | |
2/16/24 21:42 | 2/15/24 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 31 | 30 | 135 | D | | | | | | | | | | | | | | |
2/16/24 21:42 | 2/16/24 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | DO | CEO,P | S.d | -12 | 1.08 | 0 | -12 | -8 | 135 | D | | | | | | | | | | | | | | |
10/31/23 21:40 | 10/27/23 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 28 | 32 | 116 | D | | | | | | | | | | | | | | |
10/31/23 21:40 | 10/30/23 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | DO | CEO,P | S.d | -12 | 1.35 | 0 | -9 | -7 | 116 | D | | | | | | | | | | | | | | |
1/28/20 16:07 | 1/26/20 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | O | CEO,P | M.d | 0 | 0.00 | 0 | 20 | 156 | 33 | D | | | | | | | | | | | | | | |
1/29/19 18:52 | 1/26/19 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | O | See Rema | M.d | 0 | 0.00 | 0 | 12 | 999% | 13 | D | | | | | | | | | | | | | | |
1/29/19 18:52 | 1/28/19 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | O | See Rema | S.d | -25 | 5.75 | 0 | -4 | -25 | 13 | D | | | | | | | | | | | | | | |
1/30/18 21:01 | 1/26/18 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | O | See Rema | M.d | 0 | 0.00 | 0 | 8 | | 5 | D | | | | | | | | | | | | | | |
1/30/18 21:01 | 1/26/18 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | O | See Rema | S.d | -31 | 11.02 | 0 | -3 | -35 | 5 | D | | | | | | | | | | | | | | |
6/30/16 17:46 | 6/30/16 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | O | CFO,EVP | M.d | 35 | 7.79 | 11 | 5 | | 0 | D | | -28 | -18 | 12 | 10 | -9 | -1 | 5 | 3 | 3 | -61 | -53 | -64 | |
6/30/16 17:46 | 6/30/16 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | O | CFO,EVP | S.d | -134 | 29.54 | 11 | -5 | -100 | 0 | D | | -28 | -18 | 12 | 10 | -9 | -1 | 5 | 3 | 3 | -61 | -53 | -64 | |
6/29/16 19:21 | 6/27/16 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | O | CFO,EVP | M.dm | 39 | 7.79 | 11 | 5 | | 0 | D | | -23 | -16 | 17 | 16 | -14 | 0 | -3 | -3 | 1 | 20 | -56 | -68 | |
6/29/16 19:21 | 6/27/16 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | O | CFO,EVP | S.dm | -141 | 28.28 | 11 | -5 | -100 | 0 | D | | -23 | -16 | 17 | 16 | -14 | 0 | -3 | -3 | 1 | 20 | -56 | -68 | |
4/6/16 17:44 | 4/4/16 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | O | CFO,EVP | M.d | 51 | 7.79 | 7 | 7 | | 0 | D | | | 7 | -18 | 16 | 14 | 13 | 5 | 6 | 2 | -12 | -3 | -64 | -67 |
4/6/16 17:44 | 4/4/16 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | O | CFO,EVP | S.d | -189 | 28.85 | 7 | -7 | -100 | 0 | D | | | 7 | -18 | 16 | 14 | 13 | 5 | 6 | 2 | -12 | -3 | -64 | -67 |
4/4/16 19:23 | 3/31/16 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | O | CFO,EVP | M.d | 60 | 7.79 | 7 | 8 | | 0 | D | | | -7 | -23 | 16 | 9 | 10 | 8 | -1 | 10 | 5 | 3 | -57 | -62 |
4/4/16 19:23 | 3/31/16 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | O | CFO,EVP | S.d | -202 | 26.30 | 7 | -8 | -100 | 0 | D | | | -7 | -23 | 16 | 9 | 10 | 8 | -1 | 10 | 5 | 3 | -57 | -62 |
3/29/16 19:08 | 3/28/16 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | O | CFO,EVP | M.d | 43 | 7.79 | 6 | 5 | | 0 | D | | | -38 | -32 | -6 | -17 | -1 | -2 | -2 | 11 | 23 | 11 | -50 | -58 |
3/29/16 19:08 | 3/28/16 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaff Eric D. | MA | O | CFO,EVP | S.d | -132 | 24.07 | 6 | -5 | -100 | 0 | D | | | -38 | -32 | -6 | -17 | -1 | -2 | -2 | 11 | 23 | 11 | -50 | -58 |